Roche to build $283M biopharmaceutical facility in Shanghai

Roche announced plans to invest 2.04 billion yuan ($283 million) to build a new biopharmaceutical manufacturing facility in Shanghai's Pudong New Area. The facility will produce Vabysmo, a bispecific antibody for eye diseases, and is expected to be completed in 2029 and begin operations in 2031.

“Our commitment to China remains unchanged, not only today but also for the years to come, and this new site marks a significant milestone in our journey.”global.chinadaily.com.cn

• 1 source
• global.chinadaily.com.cnSwiss drugmaker to build new manufacturing facility in Shanghai - Chinadaily.com.cnMay 9, 2025

Summarized from public sources; check the original articles before acting on it.